The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
Abstract
MicroRNAs have been implicated in regulating diverse cellular pathways. Although there is emerging evidence that some microRNAs can function as oncogenes or tumour suppressors, the role of microRNAs in mediating cancer metastasis remains unexplored. Here we show, using a combination of mouse and human cells, that microRNA-10b (miR-10b) is highly expressed in metastatic breast cancer cells and positively regulates cell migration and invasion. Overexpression of miR-10b in otherwise non-metastatic breast tumours initiates robust invasion and metastasis. Expression of miR-10b is induced by the transcription factor Twist, which binds directly to the putative promoter of mir-10b (MIRN10B). The miR-10b induced by Twist proceeds to inhibit translation of the messenger RNA encoding homeobox D10, resulting in increased expression of a well-characterized pro-metastatic gene, RHOC. Significantly, the level of miR-10b expression in primary breast carcinomas correlates with clinical progression. These findings suggest the workings of an undescribed regulatory pathway, in which a pleiotropic transcription factor induces expression of a specific microRNA, which suppresses its direct target and in turn activates another pro-metastatic gene, leading to tumour cell invasion and metastasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This expression pattern is different from those of the other cancer-associated miRNAs, for example, miR-10b, which is often elevated in grade III and even grade II gliomas (Fig. 1) and dysregulated in some other cancers (41).”
From MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators (2008) · cites this paper as [41]
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1997 · Cited by 7,668
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature reviews. Cancer · doi:10.1038/nrc822 · Cited by 6,767
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Prediction of Mammalian MicroRNA Targets
Lewis, B. P., Shih, I.-H., Jones-Rhoades, M. W., Bartel, D. P., & Burge, C. B. (2003) · Cell · doi:10.1016/s0092-8674(03)01018-3 · Cited by 5,199
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686
Combinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,096
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Cited by
Sorted by citations
Items 801–900 of 1,004
Pishkari, S., Paryan, M., Hashemi, M., Baldini, E., & Mohammadi‐Yeganeh, S. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0735-6 · Cited by 73
LncRna CPS1-IT1 Suppresses Cell Proliferation, Invasion and Metastasis in Colorectal Cancer
Zhang, W., Yuan, W., Song, J., Wang, S., & Gu, X. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485091 · Cited by 73
Differential microRNA expression in breast cancer with different onset age
Tsai, H.-P., Huang, S., Li, C.-F., Chien, H., & Chen, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191195 · Cited by 73
Collins‐Burow, B. M. (2011) · Oncology Reports · doi:10.3892/or.2011.1488 · Cited by 73
Bourguignon, L., Wong, G., & Shiina, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.700021 · Cited by 72
The dual roles of homeobox genes in vascularization and wound healing
Kachgal, S., Mace, K. A., & Boudreau, N. J. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.22164 · Cited by 72
Sandhu, R., Rivenbark, A. G., Mackler, R. M., Livasy, C., & Coleman, W. B. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2197 · Cited by 72
Fujiwara, T., Katsuda, T., Hagiwara, K., Kosaka, N., Yoshioka, Y., Takahashi, R., Takeshita, F., Kubota, D., Kondo, T., Ichikawa, H., et al. (2013) · Stem Cells · doi:10.1002/stem.1618 · Cited by 72
The Therapeutic Potential of MicroRNAs: Disease Modulators and Drug Targets
McDermott, A. M., Heneghan, H., Miller, N., & Kerin, M. J. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0550-2 · Cited by 74
Munagala, R., Aqil, F., Vadhanam, M. V., & Gupta, R. C. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.06.012 · Cited by 72
Secretory miRNAs as novel cancer biomarkers
Zhang, J., Zhao, H., Gao, Y., & Zhang, W. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.03.001 · Cited by 76
Malhotra, M., Sekar, T. V., Ananta, J. S., Devulapally, R., Afjei, R., Babikir, H. A., Paulmurugan, R., & Massoud, T. F. (2018) · Oncotarget · doi:10.18632/oncotarget.25135 · Cited by 71
Shi, D., Wang, Y., Xing, A., Gao, J., Zhang, H., Guo, X., & Gao, P. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.08.029 · Cited by 71
Calore, F., Lovat, F., & Garofalo, M. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140817085 · Cited by 71
Xie, H.-Y., Shao, Z., & Li, D. (2017) · 癌症:英文版 · doi:10.1186/s40880-017-0202-y · Cited by 76
Ahmed, F., Ijaz, B., Ahmad, Z., Farooq, N., Sarwar, M. B., & Husnaın, T. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153168 · Cited by 73
Molecular Mechanisms Underlying Lymphovascular Invasion in Invasive Breast Cancer
Aleskandarany, M. A., Sonbul, S. N., Mukherjee, A., & Rakha, E. A. (2015) · Pathobiology · doi:10.1159/000433583 · Cited by 72
Small is beautiful: microRNAs and breast cancer—where are we now?
Verghese, E. T., Hanby, A., Speirs, V., & Hughes, T. A. (2008) · The Journal of Pathology · doi:10.1002/path.2359 · Cited by 70
MicroRNA regulation of melanoma progression
Bonazzi, V., Stark, M. S., & Hayward, N. K. (2011) · Melanoma Research · doi:10.1097/cmr.0b013e32834f6fbb · Cited by 70
Feng, X., Wu, Z., Yong-sheng, W., Hankey, W., Prior, T. W., Li, L., Ganju, R. K., Shen, R. Z., & Zou, X. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05523-11 · Cited by 71
MicroRNA Expression Signatures in Solid Malignancies
Galasso, M., Sandhu, S. K., & Volinia, S. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e318258b5f4 · Cited by 71
Significance of microRNA 21 in gastric cancer
Sekar, D., Ramalingam, K., Thirugnanasambantham, K., Rajasekaran, B., Islam, V. I. H., & Sekar, P. (2016) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2016.02.010 · Cited by 75
miR-10b-5p is a novel Th17 regulator present in Th17 cells from ankylosing spondylitis
Chen, L., Al‐Mossawi, H., Ridley, A., Sekine, T., Hammitzsch, A., de Wit, J., Simone, D., Shi, H., Penkava, F., Kurowska‐Stolarska, M., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210175 · Cited by 71
MicroRNAs in the pathophysiology and treatment of status epilepticus
Henshall, D. C. (2013) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00037 · Cited by 69
What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?
Palmini, G., Marini, F., & Brandi, M. L. (2017) · Molecules · doi:10.3390/molecules22030417 · Cited by 70
From latency to overt bone metastasis in breast cancer: potential for treatment and prevention
Salvador, F., Lope, A. L., & Gomis, R. R. (2019) · The Journal of Pathology · doi:10.1002/path.5292 · Cited by 73
Yesilkanal, A. E., & Rosner, M. R. (2014) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2014012000 · Cited by 70
Liu, X., Zhang, L., Cheng, K., Wang, X., Ren, G., & Xie, P. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.12.035 · Cited by 69
Stat3 Mediates Expression of Autotaxin in Breast Cancer
Azare, J., Doane, A. S., Leslie, K., Chang, Q., Berishaj, M., Nnoli, J., Mark, K. G., Al‐Ahmadie, H. A., Gerald, W. L., Hassimi, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027851 · Cited by 71
Bryant, A. J., Palma, C. A., Jayaswal, V., Yang, Y. W., Lutherborrow, M. A., & David, D. F. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-8 · Cited by 73
Diet, MicroRNAs and Prostate Cancer
Saini, S., Majid, S., & Dahiya, R. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0086-x · Cited by 68
Quantitative analysis of zeptomole microRNAs based on isothermal ramification amplification
Yao, B., Li, J., Huang, H., Sun, C., Wang, Z., Fan, Y., Chang, Q., Li, S., & Xi, J. (2009) · RNA · doi:10.1261/rna.1555209 · Cited by 70
MicroRNA involvement in the pathogenesis and management of breast cancer
Khoshnaw, S. M., Green, A. R., Powe, D. G., & Ellis, I. O. (2009) · Journal of Clinical Pathology · doi:10.1136/jcp.2008.060681 · Cited by 68
Insights into the key roles of epigenetics in matrix macromolecules-associated wound healing
Piperigkou, Z., Götte, M., Theocharis, A. D., & Karamanos, N. K. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.10.008 · Cited by 72
RhoA can lead the way in tumor cell invasion and metastasis
Amanda, P. A. (2010) · Frontiers in bioscience · doi:10.2741/3830 · Cited by 69
Heinzelmann, J., Unrein, A., Wickmann, U., Baumgart, S., Stapf, M., Szendrői, A., Grimm, M., Gajda, M. R., Wunderlich, H., & Junker, K. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3361-3 · Cited by 69
Triple negative breast cancer in the era of miRNA
Sabit, H., Çevik, E., Tombuloğlu, H., Abdel-Ghany, S. E., Tombuloğlu, G., & Esteller, M. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103196 · Cited by 69
Krüppel-like factors in cancer progression: three fingers on the steering wheel
Limame, R., de Beeck, K. O., Lardon, F., de Wever, O., & Pauwels, P. (2013) · OncoTarget · doi:10.18632/oncotarget.1456 · Cited by 69
Cyclin A2, Rho GTPases and EMT
Bendris, N., Arsic, N., Lemmers, B., & Blanchard, J. M. (2012) · Small GTPases · doi:10.4161/sgtp.20791 · Cited by 69
MicroRNA-543 suppresses endometrial cancer oncogenicity via targeting FAK and TWIST1 expression
Li, B., Chen, H., Li-xin, S., & Gao, W. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3219-3 · Cited by 69
MicroRNA‐93 regulates collagen loss by targeting MMP3 in human nucleus pulposus cells
Jing, W., & Jiang, W. (2015) · Cell Proliferation · doi:10.1111/cpr.12176 · Cited by 69
COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation
Majumder, M., Landman, E., Liu, L., Hess, D. A., & Lala, P. K. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0543 · Cited by 70
miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM
Yue, S., Wang, L., Zhang, H., Min, Y., Lou, Y., Sun, H., Jiang, Y., Zhang, W., Aming, L., Guo, Y., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-3372-8 · Cited by 68
Okamoto, H., Matsumi, Y., Hoshikawa, Y., Takubo, K., Ryoke, K., & Shiota, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043800 · Cited by 68
Alam, K. J., Mo, J., Han, S., Park, W., Kim, H., Yun, K., & Chae, S. (2017) · International Journal of Cancer · doi:10.1002/ijc.30861 · Cited by 68
Kim, W. H., Lee, J. U., Song, S., Kim, S., Choi, Y. J., & Sim, S. J. (2019) · The Analyst · doi:10.1039/c8an01745j · Cited by 72
Exosomes: A Potential Therapeutic Tool Targeting Communications between Tumor Cells and Macrophages
Guo, W., Li, Y., Pang, W., & Shen, H. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.06.003 · Cited by 68
The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer
Adinew, G. M., Taka, E., Mendonca, P., Messeha, S. S., & Soliman, K. F. A. (2021) · Nutrients · doi:10.3390/nu13041212 · Cited by 71
Metastasis suppressors and the tumor microenvironment
Cook, L. M., Hurst, D. R., & Welch, D. R. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.12.005 · Cited by 67
TargetingmiR-205in breast cancer
Wu, H., & Mo, Y. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903338777 · Cited by 68
Epigenetic modifications in rheumatoid arthritis
Strietholt, S., Maurer, B., Peters, M. A., Pap, T., & Gay, S. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2500 · Cited by 71
Aberrant expression of microRNAs in gastric cancer and biological significance of miR-574-3p
Su, Y., Ni, Z., Wang, G., Cui, J., Wei, C., Wang, J., Yang, Q., Xu, Y., & Li, F. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.05.016 · Cited by 68
Bernard, F., Krejčí, A., Housden, B. E., Adryan, B., & Bray, S. J. (2010) · Development · doi:10.1242/dev.053181 · Cited by 70
The role of miRNAs in Cancer: From Pathogenesis to Therapeutic Implications
Seven, M., Karataş, Ö. F., Düz, M. B., & Özen, M. (2014) · Future Oncology · doi:10.2217/fon.13.259 · Cited by 68
miR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4
Feng, T., Xu, D., Tu, C., Li, W., Ning, Y., Ding, J., Wang, S., Yuan, L., Xu, N., Qian, K., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-3275-8 · Cited by 68
Calaluce, R., Gubin, M. M., Davis, J. W., Magee, J., Chen, J., Kuwano, Y., Gorospe, M., & Atasoy, U. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-126 · Cited by 69
Ko, H. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.06.093 · Cited by 68
The human miRNA repertoire of different blood compounds
Leidinger, P., Backes, C., Meder, B., Meese, E., & Keller, A. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-474 · Cited by 67
Yang, L., Yang, J., Li, J., Shen, X., Le, Y., Zhou, C., Wang, S., Zhang, S., Xu, D., & Gong, Z. (2015) · Scientific Reports · doi:10.1038/srep13677 · Cited by 67
RetractedIsmail, A., El‐Mahdy, H. A., Abulsoud, A. I., Sallam, A.-A. M., Eldeib, M. G., Elsakka, E. G. E., Zaki, M. B., & Doghish, A. S. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.10.241 · Cited by 67
Up-regulation of microRNA-10b is associated with the development of breast cancer brain metastasis.
Ahmad, A., Sethi, S. N., Chen, W., Ali‐Fehmi, R., Mittal, S., & Sarkar, F. H. (2014) · PubMed Central · Cited by 67
Wang, W., Ho, P. Y., Chen, Q., Addepalli, B., Limbach, P. A., Li, M., Wu, W., Jilek, J. L., Qiu, J., Zhang, H., et al. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.225631 · Cited by 67
MicroRNA-20a Overexpression Inhibited Proliferation and Metastasis of Pancreatic Carcinoma Cells
Yan, H., Wu, J., Liu, W., Zuo, Y., Chen, S., Zhang, S., Zeng, M., & Huang, W. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.061 · Cited by 67
Zhou, P., Xu, W., Peng, X., Luo, Z., Xing, Q., Chen, X., Hou, C., Liang, W., Zhou, J., Wu, X., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068204 · Cited by 68
microRNAs, an active and versatile group in cancers
Liu, J., Zheng, M. H., Tang, Y., Liang, X., & Yang, Q. (2011) · International Journal of Oral Science · doi:10.4248/ijos11063 · Cited by 67
Xia, Z., Clark, P., Huynh, T., Loher, P., Zhao, Y., Chen, H.-W., Rigoutsos, I., & Zhou, R. (2012) · Scientific Reports · doi:10.1038/srep00569 · Cited by 69
Xia, W., Li, J., Chen, L., Huang, B., Li, S., Yang, G., Ding, H., Wang, F., Liu, N., Zhao, Q., et al. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0550-2 · Cited by 67
MicroRNA-196b Regulates the Homeobox B7-Vascular Endothelial Growth Factor Axis in Cervical Cancer
How, C., Hui, A. B., Alajez, N. M., Shi, W., Boutros, P. C., Clarke, B. A., Yan, R., Pintilie, M., Fyles, A., Hedley, D. W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067846 · Cited by 67
Vitali, R., Mancini, C., Cesi, V., Tanno, B., Mancuso, M., Bossi, G., Zhang, Y., Martinez, R. V. P., Calabretta, B., Dominici, C., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5210 · Cited by 68
Zhao, Q., Piao, J., Peng, W., Wang, Y., Zhang, B., Gong, X., & Chang, J. K. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b16733 · Cited by 67
Xu, M., Almasi, S., Yang, Y., Yan, C. W., Sterea, A. M., Syeda, A. K. R., Shen, B. Q., Clements, D. R., Huang, P., Gujar, S. A., et al. (2019) · Cell Calcium · doi:10.1016/j.ceca.2019.02.010 · Cited by 70
microRNA expression profiles in human colorectal cancers with brain metastases
Li, Z., Gu, X., Fang, Y., Xiang, J., & Chen, Z. (2011) · Oncology Letters · doi:10.3892/ol.2011.497 · Cited by 66
Ma, L. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.07.004 · Cited by 69
Self-citationMicroRNA-10b expression in breast cancer and its clinical association
Zhang, J., Yang, J. L., Zhang, X., Xu, J., Sun, Y., & Zhang, P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192509 · Cited by 66
Moreno, C. S. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090657 · Cited by 67
Wang, L., Chen, S., Xue, M., Zhong, J., Wang, X., Gan, L., Lam, E. K. Y., Liu, X., Zhang, J., Zhou, T., et al. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00172 · Cited by 66
miR-223 Is a Coordinator of Breast Cancer Progression as Revealed by Bioinformatics Predictions
Pinatel, E., Orso, F., Penna, E., Cimino, D., Elia, A. R., Circosta, P., Dentelli, P., Brizzi, M. F., Provero, P., & Taverna, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084859 · Cited by 69
Role of CSF-1 in Progression of Epithelial Ovarian Cancer
Chambers, S. K. (2009) · Future Oncology · doi:10.2217/fon.09.103 · Cited by 64
MicroRNAs involved in neoplastic transformation of liver cancer stem cells
Ren, L., Qian, N., Tao, K., You, N., Wang, X., & Dou, K. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-169 · Cited by 67
Non-coding RNAs: the cancer genome dark matter that matters!
Ling, H. Y., Girnita, L., Buda, O., & Călin, G. A. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0740 · Cited by 67
Schwarzenbach, H. (2017) · Oncology Research and Treatment · doi:10.1159/000478019 · Cited by 67
COX-2 induces oncogenic micro RNA miR655 in human breast cancer
Majumder, M., Dunn, L., Liu, L., Hasan, A., Vincent, K. M., Brackstone, M., Hess, D. A., & Lala, P. K. (2018) · Scientific Reports · doi:10.1038/s41598-017-18612-3 · Cited by 63
The roles of microRNAs in tumorigenesis and angiogenesis.
Yang, W., Lee, D. Y., & Ben‐David, Y. (2011) · PubMed Central · Cited by 66
Li, S., Meng, H., Zhou, F., Zhai, L., Zhang, L., Gu, F., Yu, F., Lang, R., Fu, L., Gu, L., et al. (2013) · Pathology - Research and Practice · doi:10.1016/j.prp.2012.12.002 · Cited by 65
Epigenetic disruption of cadherin‐11 in human cancer metastasis
Carmona, F. J., Villanueva, A., Vidal, A., Muñoz, C., Puertas, S., Penin, R. M., Gomà, M., Lujambio, A., Piulats, J. M., Mesı́a, R., et al. (2012) · The Journal of Pathology · doi:10.1002/path.4011 · Cited by 65
MicroRNA-Based Diagnosis and Treatment of Metastatic Human Osteosarcoma
Sasaki, R., Osaki, M., & Okada, F. (2019) · Cancers · doi:10.3390/cancers11040553 · Cited by 66
Hua, L., Zhang, Q., Zhu, X., Wang, R., You, Q., & Wang, L. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00316 · Cited by 69
miR‐10a restores human mesenchymal stem cell differentiation by repressing KLF4
Li, J., Dong, J., Zhang, Z., Zhang, D., You, X., Zhong, Y., Chen, M., & Liu, S. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24402 · Cited by 65
MicroRNAs in the control of metastatic bone disease
Browne, G., Taipaleenmäki, H., Stein, G. S., Stein, J. L., & Lian, J. B. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.03.014 · Cited by 65
Zhang, Z., Liu, Z.-B., Ren, W., Ye, X.-G., & Zhang, Y. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1059 · Cited by 65
MetastamiRs: Non-Coding MicroRNAs Driving Cancer Invasion and Metastasis
López‐Camarillo, C., Marchat, L. A., Aréchaga-Ocampo, E., Pérez‐Plasencia, C., Moral-Hernández, Ó. D., Castaneda-Ortiz, E. J., & Rodriguez-Cuevas, S. A. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13021347 · Cited by 67
Nazarenko, M. S., Markov, A., Лебедев, И. Н., Freidin, M. B., Sleptcov, A. A., Koroleva, I. A., Frolov, A. V., Va, P., Барбараш, О. Л., & Puzyrev, V. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122601 · Cited by 65
micro RNA ‐762 promotes breast cancer cell proliferation and invasion by targeting IRF 7 expression
Li, Y., Huang, R., Wang, L., Hao, J., Zhang, Q., Ling, R., & Yun, J. (2015) · Cell Proliferation · doi:10.1111/cpr.12223 · Cited by 65
Ma, Y., Zhang, P., Wang, F., Moyer, M. P., Yang, J., Liu, Z., Peng, J.-Y., Chen, H., Zhou, Y.-K., Liu, W., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01170.x · Cited by 65
miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1
Chen, M. L., Liang, L. S., & Wang, X. K. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9463-7 · Cited by 66
Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes
Liu, Y., Cai, Q., Bao, P., Su, T., Cai, H., Wu, J., Ye, F., Guo, X., Zheng, W., Zheng, Y., et al. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3460-x · Cited by 66
Khella, H. W. Z., White, N. M. A., Faragalla, H., Gabril, M. Y., Boazak, M., Dorian, D., Khalil, B., Antonios, H., Bao, T. T., Pasic, M. D., et al. (2011) · Tumor Biology · doi:10.1007/s13277-011-0255-5 · Cited by 64
Tumor suppressor microRNAs: A novel non‐coding alliance against cancer
Blandino, G., Fazi, F., Donzelli, S., Kedmi, M., Sas‐Chen, A., Muti, P. C., Strano, S., & Yarden, Y. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.03.033 · Cited by 65
miR-1307-3p Stimulates Breast Cancer Development and Progression by Targeting SMYD4
Han, S., Zou, H., Lee, J.-W., Han, J. H., Kim, H. C., Cheol, J. J., Kim, H., & Kim, H. (2019) · Journal of Cancer · doi:10.7150/jca.30041 · Cited by 64
The Sequence Structures of Human MicroRNA Molecules and Their Implications
Fang, Z., Du, R., Edwards, A., Flemington, E. K., & Zhang, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054215 · Cited by 64
Metadata
- Authors
- Ma, L., Teruya-Feldstein, J., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Weinberg, Robert A.
- Venue
- Nature
- Published
- 2007-09-26
- Volume
- 449
- Issue
- 7163
- Pages
- 682-688
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2047529648
- Cited by
- 2,605
- References
- 49
- Citations by year
- 2026: 34 · 2025: 36 · 2024: 66 · 2023: 69 · 2022: 75 · 2021: 120 · 2020: 106 · 2019: 123 · 2018: 113 · 2017: 151 · 2016: 160 · 2015: 196 · 2014: 215 · 2013: 226 · 2012: 220
- FWCI
- 60.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- microRNA-10b, breast cancer, metastasis, tumor invasion, cell migration, Twist transcription factor, HOXD10, RhoC, Hox genes, microRNA target regulation, clinical progression
- MeSH terms
- rhoC GTP-Binding Protein, Animals, Base Sequence, Breast Neoplasms, Cell Movement, Humans, Lung Neoplasms, Neoplasm Invasiveness, Neoplasm Metastasis, Peritoneal Neoplasms, Transcription Factors, Gene Expression Regulation, Neoplastic, Homeodomain Proteins, rho GTP-Binding Proteins, MicroRNAs, Cell Line, Tumor, Mice, Twist-Related Protein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review